Novartis says Cosentyx effective for nail, palmoplantar psoriasis

30th November 2017 Uncategorised 0

Novartis says Cosentyx is the first biologic to show long-term efficacy in nail and palmoplantar psoriasis, which can impact up to 90 percent of psoriasis patients.

More: Novartis says Cosentyx effective for nail, palmoplantar psoriasis
Source: News